ADHD Statistics in Oregon

Attention-Deficit/Hyperactivity Disorder (ADHD) is one of the most frequently diagnosed neurodevelopmental disorders among children in the United States, affecting millions of families^[9]. In Oregon, the condition represents a significant public health consideration, with diagnosis and treatment rates that provide insight into the state's mental healthcare landscape. Understanding the prevalence of ADHD is the first step in assessing the adequacy of resources, identifying treatment gaps, and addressing disparities in care.

Nationally, the prevalence of parent-reported ADHD diagnoses in children varies widely, ranging from as low as 6.1% in California to as high as 16.3% in Louisiana^[3]. Oregon's rates fall within a moderate range compared to other states, but the figures still represent a substantial number of children and families navigating the challenges of ADHD.

Timely and appropriate treatment for ADHD is crucial for improving long-term academic and social outcomes^[8]. National clinical guidelines recommend a balanced approach combining medication and evidence-based behavioral interventions^[12]. For children under six, behavior therapy is recommended as the first line of treatment^[12]. Oregon's data reveals a complex picture of treatment utilization, with notable strengths and significant gaps in care.

While Oregon ranks 4th among peer states for children receiving combined treatment, indicating strong performance in some areas, a closer look shows that many children are not receiving this comprehensive standard of care^[10]. The following data compares the rates of the two primary treatment modalities for children with a current ADHD diagnosis in the state.

Despite Oregon's relatively high rates of individual treatment types, a substantial gap remains in ensuring all diagnosed children receive adequate care. Data shows that approximately 70.2% of Oregon children with ADHD receive some form of treatment, which means nearly 30% receive no ADHD-specific intervention at all^[3]. This gap is even more pronounced when considering the gold standard of combined therapy.

Untreated ADHD is associated with higher risks of academic underachievement, substance misuse, and behavioral challenges that can persist into adulthood^[6]. The following statistics highlight the difference between receiving any treatment versus the comprehensive care recommended by clinicians.

ADHD diagnosis and treatment are not experienced uniformly across all populations. National data shows that ADHD diagnoses are significantly more common in boys (approximately 13%) than in girls (around 6%)^[9]. Furthermore, socioeconomic factors like family income, insurance status, and language spoken at home are associated with both the likelihood of diagnosis and the type of treatment received^[10].

In Oregon, these disparities are particularly evident in treatment access for racial and ethnic minorities. Systemic barriers, including a lack of bilingual providers, can leave minority populations underserved^[6]. The following table breaks down key demographic statistics for both Oregon and the U.S.

Access to specialized healthcare is a critical component of managing ADHD, yet many Oregonians face significant hurdles. A primary challenge is the statewide shortage of mental health providers, with many counties designated as Health Professional Shortage Areas (HPSAs)^[1]. This shortage is particularly acute in rural regions, where long travel distances and a lack of specialists create 'mental health care deserts,' leaving nearly 9% of the state's residents underserved^[4].

While 95% of children on Medicaid have full coverage for ADHD treatment, broader insurance coverage for mental health services in Oregon (85%) is slightly below the national average (90%)^[10][15]. The geographic disparity in provider density underscores how a child's access to care can depend heavily on their location.

The rate of ADHD diagnosis has not been static. Over the past several decades, there has been a clear upward trend in the number of children identified with ADHD. Nationally, the percentage of U.S. children with a diagnosis nearly doubled from 5.5% in 1997 to 9.8% in 2018^[9]. This shift reflects greater awareness, evolving diagnostic criteria, and changing societal views on mental health.

More recently, data from British Columbia showed a more than three-fold increase in adult ADHD incidence post-pandemic, with a particularly sharp 168.4% jump in new diagnoses among females^[11]. While this data is not specific to Oregon, it suggests a broader trend of increased recognition and diagnosis in adults that may also be occurring in the state. The chart below illustrates the long-term rise in childhood diagnoses in the U.S.

ADHD often co-occurs with other mental health conditions, such as anxiety and depression, which can complicate diagnosis and treatment^[8]. There is also a strong correlation between ADHD and substance use disorder (SUD). Research shows that adults with a history of SUD or any other mental disorder have ADHD incidence rates approximately five times higher than those without such a history^[11]. The economic impact of untreated ADHD is also significant, placing a burden on educational systems, healthcare providers, and the community due to long-term societal costs^[16].